联合王国的国民保健制度在25年后开始将国内捐赠的等离子体用于药品,目的是减少进口依赖。 The UK's NHS starts using domestically donated plasma for medicines after 25 years, aiming to reduce import reliance.

联合王国的国民保健制度目前使用国内捐助者的血浆生产25年来首次救生药品。 The NHS in the UK is now using plasma from domestic donors to produce life-saving medicines for the first time in 25 years. 这一举措减少了对进口治疗的依赖,并为条件罕见的病人提供了支持。 This move reduces reliance on imported treatments and supports patients with rare conditions. 过去三年来,埃塞克斯捐赠者提供了约12 000升血浆,足以生产5 400瓶免疫球蛋白,每年可以拯救或改善约140人的生活。 Over the past three years, Essex donors have provided around 12,000 liters of plasma, enough to produce 5,400 bottles of immunoglobulin, which can save or improve the lives of about 140 people annually. 国民保健制度的目标是到2025年底使免疫球蛋白的自给自足率达到25%,到明年使蛋白的自给自足率达到80%。 The NHS aims to reach 25% self-sufficiency in immunoglobulin by the end of 2025 and 80% in albumin by next year.